Loading...

IHH gets license to set up Shanghai joint venture

Image

02-Jul-15 IHH Healthcare, owner of Southeast Asia's largest private healthcare provider Parkway Pantai, has secured a license to establish and own 70% of Parkway Health Shanghai Intl Hospital Co Ltd in Shanghai. The remaining 30% of the company, which is licensed to provide multi-specialty hospital in-patient and out-patient services, is owned by IHH's partner Shanghai Hongxin Medical Investment Holding Co Ltd. [image: 15 Minute News]

Read More

China pushes traditional Chinese medicine abroad

Image

30-Jun-15 The Chinese government will support domestic hospitals in promoting Chinese medicine worldwide, the Overseas Chinese Affairs Office of the State Council has said. It is encouraging domestic hospitals to foster ties with hospitals in other counties run by overseas Chinese and to set up Chinese medicine centres abroad. [image: UPI / Stephen Shaver]

Read More

China-Australia FTA opens up investor access

Image

18-Jun-15 The China-Australia Free Trade Agreement (ChAFTA) was officially signed on 17-Jun-15. ChAFTA increases Australian investors’ ability to own medical facilities either wholly or by majority JV, enables some Australian physicians to offer services in China, permits wholly Australian-owned aged care institutions, and promotes cooperation in the field of Traditional Chinese Medicine. [image: The Conversation]

Read More

Russia masterminds an International Medical Cluster

Image

18-Jun-15 Russia's Duma, the lower house of parliament, passed a draft bill on the development of an “International Medical Cluster”, to be piloted in the Skolkovo innovation hub outside Moscow. Its goals include further medical development, transfer of advanced technologies into Russia, and the provision of high-quality medical assistance for populations. [image: Wikicommons]

Read More

Merck flaunts Russian expansion

Image

18-Jun-15 Merck's Russian expansion drive remains unaltered, its top executives say, despite a looming recession, a state localization drive, and deteriorating relations with the West. Merck is increasing headcount and expects to improve on its EUR150 mn sales of 2014. "It is crucial to capture the niche markets," said Jurgen Konig, head of Merck in Russia. [image: Armin Kübelbeck / Wikicommons]

Read More
Share